-+ 0.00%
-+ 0.00%
-+ 0.00%

BEONE MEDICINES REPORTS SUSTAINED SURVIVAL BENEFIT WITH TEVIMBRA-ZIIHERA COMBINATION IN FIRST-LINE HER2+ GASTROESOPHAGEAL CANCER

Reuters·10/23/2026 14:17:06